Page 3 - Project Baseline News Today

Amy Abernethy, FDA veteran, joins Verily as tech firm plots next steps.

Healthcare

(Photo credit: Getty Images/Westend61) Over the last year, digital has transformed the caregiver experience, but pharma has also been undergoing a metamorphosis in order to reach patients. During the pandemic, life science companies were pushed to reconfigure their care in order to meet the needs of some of the most at-risk patients. MobiHealthNews sat down with the leader of pharma giant Otsukas Global Clinical Development on Nephrology, Dr. Charlotte Jones-Burton, to talk about innovating ...

MedCity News Otsuka launches pivotal trial of digital therapeutics for depression Otsuka Pharmaceutical is partnering with Click Therapeutics to launch a remote clinical trial to evaluate the effectiveness of digital therapeutics in reducing depressive symptoms. Shares0 Otsuka Pharmaceutical is launching a virtual study to see if digital therapeutics can reduce depression symptoms. It’s the next step in a partnership between the Tokyo-based drugmaker and Click Therapeutics, a digital health...

Daiichi Sankyo, Clover Biopharmaceuticals and Insilico Medicine made our news this week. (Google) Amid a big cancer push, Daiichi Sankyo lured Kite Pharma exec Ken Takeshita to lead its R&D work. Chinas Clover Biopharmaceuticals secured $230 million in an oversubscribed series C to help advance its COVID-19 vaccine program and expand manufacturing capabilities. In several firsts for artificial-intelligence-based drug discovery, Insilico Medicine discovered a novel target for idiopathic pulmon...

Google sister Verily was touted early in the pandemic as a promising coronavirus testing option.

Share Otsuka Pharmaceutical and Click Therapeutics have announced the launch of a new, fully remote clinical trial being conducted on Verilys Project Baseline platform. Called the Mirai study, it will be measuring a digital therapeutics interventions effectiveness in reducing symptoms of depression among adults who have a major depressive disorder (MDD) diagnosis and are on antidepressant monotherapy. Christoph Koenen, EVP and chief medical officer of Ostuka Pharmaceutical Companies U.S., ...

Gmail finally reveals all data it collects from phone users, adds privacy labels to iOS app After YouTube, Gmail now becomes the second most important Google app to get a privacy label. Ankita Chakravarti | February 23, 2021 | Updated 09:17 IST Highlights Google took a very long time to add labels to its major apps. After YouTube, Gmail now becomes the second most important Google app to get a privacy label. Google has finally added privacy labels to the Gmail app on Apple App Store. Google ...

The platforms creation, says Anthony Philippakis, chief data officer at the Broad Institute, was driven by two trends within the wider biomedical space: an explosion in the volume and types of data available – from genomics data to medical imaging and electronic health records – alongside a greater need for data sharing within biomedical science. SEE: (TechRepublic) "No one organisation, whether it be a medical centre, or a university, or a company, has enough data in order to go after pr...

Verily joins with Janssen, adding Covid-19 to Project Baseline study Verily and Janssen say studying Covid-19 immune responses could yield data that helps clinicians treat the disease. They add that the research could also apply to other illnesses caused by respiratory pathogens. Shares0   When Verily unveiled $700 million in funding late last year, it said the cash would support its Covid-19 research. Some of those research plans are now taking shape. Verily, the life sciences division of Go...